The DISCUS trial demonstrated improved QOL with 3 cycles of chemotherapy compared to 6 cycles in advanced urothelial cancer patients. Both treatment arms showed similar overall survival and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback